A panel of judges has ruled that all federal lawsuits alleging kidney injuries from proton pump inhibitor (PPI) heartburn medications will be centralized in the District of New Jersey for pretrial handling.
Free Confidential Lawsuit Evaluation: If you or a loved one was injured by proton pump inhibitor side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
What’s the Problem?
August 4, 2017 – The U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a Transfer Order (PDF) Wednesday, transferring at least 161 lawsuits filed on behalf of patients who allegedly suffered kidney damage after taking proton pump inhibitors. Another 24 cases may soon be transferred to the MDL, as well as any other federal PPI kidney disease lawsuits that may be filed in the future, according to the JPML.
The class of proton pump inhibitors includes:
- Nexium (esomeprazole)
- Aciphex (rabeprazole)
- Protonix (pantoprazole)
- Prevacid (lansoprazole)
- Zegerid (omeprazole / sodium bicarbonate)
- Dexilant (dexlansoprazole)
- Prilosec (omeprazole)
In recent years, numerous studies have demonstrated that long-term PPI use can increase a person’s risk for adverse kidney complications. In April 2016, for example, a study published in the Journal of the American Society of Nephrology (JASN) found that long-term PPI users were 96% more likely to develop kidney failure and 28% more likely to develop CKD compared to patients using another class of heartburn drugs known as H2-blockers (Pepcid, Zantac). Additional research published in JAMA Internal Medicine in January 2016 also suggested that PPIs may increase the risk of CKD by as much as 50%.
JPML in February denied a motion seeking centralization of proton pump inhibitor lawsuits after noting only a small number claims filed (15) and the complexities involved with bringing so many different medications together into a single litigation. In agreeing to consolidate the suits, the panel noted that the number of filings had increased significantly, and that 2 defendants, AstraZeneca and Pfizer, had changed course and were in support of the MDL.
Do I Have a PPI Class Action Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in proton pump inhibitor lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
Free Case Evaluation: Again, if you were harmed by Nexium, Prilosec or other PPI heartburn drug, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.